Pharma major Biocon is set to announce its quarterly results on November 11, with analysts expecting a mixed performance across segments. According to Axis Securities Equity Research, the Biosimilars ...

In a move aimed at expanding affordable treatment options for millions of Americans living with diabetes, Biocon Biologics Ltd. and nonprofit generic drug manufacturer Civica, Inc. have announced a ...

Biocon chief Kiran Mazumdar-Shaw has dismissed reports claiming she offered to fund Bengaluru road repairs as 'fabricated news.' She expressed amusement and challenged media outlets to reveal their ...

Dublin, Oct. 22, 2025 (GLOBE NEWSWIRE) -- The "Portable Ultrasound Bladder Scanner - Market Insights, Competitive Landscape, and Market Forecast - 2032" has been added to ResearchAndMarkets.com's ...

Kiran Mazumdar-Shaw, Biocon founder and a key voice of India Inc., met Karnataka Chief Minister Siddaramaiah and Deputy Chief Minister DK Shivakumar at their homes in Bengaluru this morning. The ...

Biocon Biologics, a global leader in biosimilars and the world’s fourth-largest insulin producer, has announced the expansion of its strategic partnership with Civica, Inc., a US-based non-profit ...

Biocon Biologics Ltd., a unit of India’s Biocon Ltd., has expanded its partnership with US-based nonprofit Civica Inc. to launch a private-label version of insulin glargine in the United States, ...

A HALF-HOUR scan could nearly halve bladder cancer deaths, a study suggests. Giving patients an MRI scan before the usual biopsy helps doctors start treatment faster, boosting survival chances. Please ...

Giving patients with suspected bladder cancer an MRI scan before surgery could mean they would be treated more quickly, leading to fewer deaths due to the disease, new research suggests. The findings, ...

Take advantage of TipRanks Premium at 50% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence. Biocon Limited ( (IN:BIOCON)) has shared ...

An India-headquartered global biopharmaceutical company is making a big bet on the Garden State. Biocon Ltd. focuses on enhancing affordable access to complex therapies for chronic conditions, such as ...